Literature DB >> 1662999

Inhibition of the Na+,K(+)-ATPase pump during induction of experimental colon cancer.

R J Davies1, G I Sandle, S M Thompson.   

Abstract

During the development of large bowel cancer alterations in colonic epithelial ion transport have been observed some of which result in altered intracellular ionic composition. In many tumors intracellular sodium and potassium become elevated and depressed, respectively. This observation suggests that mechanisms governing intracellular homeostasis for sodium and potassium are no longer tightly regulated. Changes in cell membrane permeability, sodium, potassium-ATPase K(+)-ATPase) pump activity, or both may be responsible for these alterations. It is not known when during initiation and development of cancer such changes may occur. To assess whether there are changes in the Na+, K(+)-ATPase pump early during the induction of large bowel cancer and prior to any notable histological changes, we measured the kinetics of the Na+, K(+)-pump in distal colonic mucosa of CF1 mice one week following only four weekly injections of the carcinogen 1,2-dimethyhydrazine (DMH). The kinetics of the pump were found to be best described by a model of highly cooperative binding. The VMAX of the pump in premalignant mucosa was lower for both sodium and potassium substrate activation (55-65% of control) with little change in other kinetic parameters. Depression of VMAX could not be attributed to an increased barium blockable potassium conductance of the basolateral membrane. Na+,K(+)-ATPase activity was also decreased by 50% in the distal colon of DMH treated mice, but was not affected in the less cancer susceptible proximal colon. These data demonstrate that alterations occur in the Na+,K(+)-pump in premalignant mucosa months before gross tumors develop, and these changes may partially explain the altered levels of Na+ and K+ in the cytoplasm of pre-malignant and malignant colonocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662999

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  7 in total

1.  Acylphosphatase possesses nucleoside triphosphatase and nucleoside diphosphatase activities.

Authors:  P Paoli; G Camici; G Manao; E Giannoni; G Ramponi
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K(+)-ATPase (NKA) inhibitory activity in human breast cyst fluid.

Authors:  C J Weber; D Kim; M Costanzo; J Morris; B Howe; L Ward; V D'Agati; T McDonald; T M O'Dorisio; V P Butler
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

3.  Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution.

Authors:  Edward L Huttlin; Xiaodi Chen; Gregory A Barrett-Wilt; Adrian D Hegeman; Richard B Halberg; Amy C Harms; Michael A Newton; William F Dove; Michael R Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

4.  "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?

Authors:  Heidrun Weidemann
Journal:  J Carcinog       Date:  2012-02-17

Review 5.  Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.

Authors:  Hesham R El-Seedi; Nermeen Yosri; Bishoy El-Aarag; Shaymaa H Mahmoud; Ahmed Zayed; Ming Du; Aamer Saeed; Syed G Musharraf; Islam M El-Garawani; Mohamed R Habib; Haroon Elrasheid Tahir; Momtaz M Hegab; Xiaobo Zou; Zhiming Guo; Thomas Efferth; Shaden A M Khalifa
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

6.  Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.

Authors:  Seung Joon Lee; Alisa Litan; Zhiqin Li; Bruce Graves; Stephan Lindsey; Sonali P Barwe; Sigrid A Langhans
Journal:  Mol Cancer       Date:  2015-08-19       Impact factor: 27.401

Review 7.  Oleandrin: A cardiac glycosides with potent cytotoxicity.

Authors:  Arvind Kumar; Tanmoy De; Amrita Mishra; Arun K Mishra
Journal:  Pharmacogn Rev       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.